-
Atopic
Dermatitis Restoration of skin barrier function and instant itching relief efficacy by inducing non-autoreactive regulatory T cells -
Osteoartiritis Non-surgical therapeutics with anti-inflammation and hyaline cartilage regeneration efficacy
(designed for DMOAD) -
Anti-Cancer Innovative anti-cancer therapeutics targeting abnormal Tumor Microenvironment inhibiting normal immune activities
-
Neurodegerative
Diseases EV therapeutics that pass through Blood-Brain-Barrier and normalize autophagic function to degrade abnormal reactive proteins -
Infectious
Diseases Newly discovered IgP-containing EV therapeutics applicable to prevention and treatment of all infectious diseases, including COVID-19
Copyright 2024 All rights reserved.